The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
GermlineTP53 mutations and Li-Fraumeni syndrome
Open accessAbstract
There are now reports of nearly 250 independent germline TP53 (p53) mutations in over 100 publications. Such mutations are typically associated with Li-Fraumeni or Li-Fraumeni-like syndrome, although many have been identified in cohorts of patients with tumors considered to be typical of LFS. In general, the spectrum of mutations that has been detected in the germline reflects that found in tumors, although there are some notable exceptions in certain tumor types. Detailed knowledge of the pedigrees allows a comprehensive analysis of genotype-phenotype correlations and an understanding of the tumors that are associated with germline TP53 mutations. This review will discuss the spectrum of mutations and the methods for mutation detection, the tumors associated with inheritance of a germline mutation, and some of the ethical and clinical problems in patients with a germline TP53 mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Self-citationAssessing TP53 status in human tumours to evaluate clinical outcome
Soussi, T., & Béroud, C. (2001) · Nature reviews. Cancer · doi:10.1038/35106009 · Cited by 659
Structural aspects of the p53 protein in relation to gene evolution.
Soussi, T., de Fromentel, C. C., & May, P. (1990) · PubMed · Cited by 603
Multiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
Self-citationA CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Vahteristo, P., Bartkova, J., Eerola, H., Syrjäkoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomäki, K., Heikkilä, P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341943 · Cited by 467
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues, P., Schäuble, B., Hausen, A. Z., Estève, J., & Ohgaki, H. (1997) · Europe PMC (PubMed Central) · Cited by 411
Rhabdomyosarcoma in Children: Epidemiologic Study and Identification of a Familial Caneer Syndrome
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1365 · Cited by 397
Li-Fraumeni syndrome – a molecular and clinical review
Varley, J., Evans, D., & Birch, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.328 · Cited by 358
Self-citationGerm-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
DiGiammarino, E. L., Lee, A. S., Cadwell, C., Zhang, W., Bothner, B., Ribeiro, R. C., Zambetti, G., & Kriwacki, R. W. (2002) · Nature Structural Biology · doi:10.1038/nsb730 · Cited by 294
Soussi, T., Dehouche, K., & B�roud, C. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<105::aid-humu19>3.0.co;2-g · Cited by 271
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
Self-citationGerm-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley, J. M., McGown, G., Thorncroft, M. R., Santibanez‐Koref, M., Kelsey, A. M., Tricker, K. J., Evans, D. G., & Birch, J. M. (1997) · PubMed · Cited by 263
Self-citationInherited p53 gene mutations in breast cancer.
Sidransky, D., Tokino, T., Helzlsouer, K. J., et al. (1992) · PubMed · Cited by 249
Prospective Study of a Family Cancer Syndrome
Li, F. P. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320440040031 · Cited by 244
High frequency of germline p53 mutations in childhood adrenocortical cancer
Wagner, J., Portwine, C., Rabin, K., Leclerc, J.-M., Narod, S. A., & Malkin, D. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1707 · Cited by 227 · cited 2×
“Two small studies have been reported that analyzed germline TP53 mutations in children with ACC [Sameshima et al., 1992; Wagner et al., 1994], and we subsequently investigated the frequency of germline mutations in a cohort of children with ACC unselected for family history [Varley et al.”
BackgroundGermline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
Diller, L., Sexsmith, E., Gottlieb, A., Li, F. P., & Malkin, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117834 · Cited by 220
Childhood Adrenocortical Tumors1
Sandrini, R., Ribeiro, R. C., & DeLacerda, L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4057 · Cited by 218
Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 217
Casey, G., Me, L., Jc, R., Sj, P., Arboleda, M. J., Shaughnessy, M., Karlan, B. Y., & Dj, S. (1996) · PubMed · Cited by 205
Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202033 · Cited by 200
Self-citationGermline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
McIntyre, J. F., Smith-Sorensen, B., Friend, S. H., Kassell, J., Borresen, A. L., Yan, Y. X., Russo, C., Sato, J., Barbier, N., & Miser, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.925 · Cited by 200
Screening for germ line TP53 mutations in breast cancer patients.
Børresen‐Dale, A., Andersen, T. I., Garber, J. E., Barbier, N., Thorlacius, S., Eyfjord, J. E., Ottestad, L., Smith‐Sørensen, B., Hovig, E. J., & Malkin, D. M. (1992) · PubMed · Cited by 187
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee, S. B., Kim, S. H., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Jorczak, M. M., Sgroi, D. C., Garber, J. E., Li, F. P., Nichols, K. E., et al. (2001) · PubMed · Cited by 160
Self-citationThe UMD-p53 database: New mutations and analysis tools
Béroud, C., & Soussi, T. (2003) · Human Mutation · doi:10.1002/humu.10187 · Cited by 157
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Limacher, J., Frébourg, T., Natarajan‐Amé, S., & Bergerat, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1021 · Cited by 151
Cancer in Survivors of Childhood Soft Tissue Sarcoma and Their Relatives
Strong, L. C., Stine, M. D., & Norsted, T. L. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.6.1213 · Cited by 141
Lynch, H. T., Mulcahy, G. M., Harris, R. E., Guirgis, H. A., & Lynch, J. F. (1978) · Cancer · Cited by 140
Germline p53 Gene Mutations in Subsets of Glioma Patients
Kyritsis, A. P., Bondy, M. L., Xiao, M., et al. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.344 · Cited by 133
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas
Chung, R. Y., Whaley, J. M., Kley, N., Anderson, K., Louis, D. N., Menon, A. G., Hettlich, C., Freiman, R. N., Hedley‐Whyte, E. T., Martuza, R. L., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030502 · Cited by 132
Davison, T. S., Yin, P., Nie, E., Kay, C. M., & Arrowsmith, C. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202062 · Cited by 112
Chompret, A. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01361-x · Cited by 104
Sameshima, Y., Tsunematsu, Y., Watanabe, S., Tsukamoto, T., Kawa‐Ha, K., Hirata, Y., Mizoguchi, H., Sugimura, T., Terada, M., & Yokota, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.9.703 · Cited by 91
An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.
Varley, J. M., McGown, G., Thorncroft, M. R., Tricker, K. J., Teare, M. D., Santibanez‐Koref, M., Martin, J. W., Birch, J. M., & Evans, D. G. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.942 · Cited by 83
Self-citationBougeard, G., Limacher, J. M., Martin, C., CHARBONNIER, F., Killian, A., Delattre, O., Longy, M., Jonveaux, P., FRICKER, J.-P., Stoppa‐Lyonnet, D., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.4.253 · Cited by 76
p53 gene mutations in pediatric brain tumors
Felix, C. A., Slavc, I., Dunn, M. G., Strauss, E. A., Phillips∥, P. C., RORKE, L. B., Sutton, L. N., Bunin, G. R., & Biegel, J. A. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950250603 · Cited by 75
A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families
Porter, D. E., Holden, S., Steel, C., Bb, C., Wallace, M., & Reid, R. (1992) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.74b6.1447251 · Cited by 75
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas
Birch, J. M., Hartley, A. L., Marsden, H. B., Harris, M., & Swindell, R. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.51 · Cited by 74
Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
Iavarone, A., Matthay, K. K., Steinkirchner, T., & Israel, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4207 · Cited by 71
Constitutional p53 mutations associated with brain tumors in young adults
Chen, P., Iavarone, A., Fick, J. R., Edwards, M. S. B., Prados, M., & Israel, M. A. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00213-u · Cited by 71
Lomax, M. E., Barnes, D. M., Gilchrist, R., Picksley, S. M., Varley, J. M., & Camplejohn, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201133 · Cited by 65
Self-citationCharacterization of germline TP53 splicing mutations and their genetic and functional analysis
Varley, J. M., Attwooll, C. L., White, G. R. M., McGown, G., Thorncroft, M. R., Kelsey, A. M., Greaves, M. J., Boyle, J. M., & Birch, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204369 · Cited by 62
Self-citationIncidence of germ‐line p53 mutations in patients with gliomas
Li, Y., Sanson, M., Hoang‐Xuan, K., Delattre, J., Poisson, M., Thomas, G. D., & Hamelin, R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640606 · Cited by 60
Wilms' tumor in the Li-Fraumeni cancer family syndrome
Hartley, A. L., Birch, J. M., Tricker, K. J., et al. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90166-j · Cited by 56
Constitutional p53 mutation in a non-Li-Fraumeni cancer family
Prosser, J., Porter, D., Coles, C., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.109 · Cited by 56
Genetic and functional studies of a germline TP53 splicing mutation in a Li–Fraumeni-like family
Varley, J. M., Chapman, P. J., McGown, G., Thorncroft, M. R., White, G. R. M., Greaves, M. J., Scott, D., Spreadborough, A. R., Tricker, K. J., Birch, J. M., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201878 · Cited by 52
Self-citationEvans, D. G., Birch, J. M., Thorneycroft, M., McGown, G., Lalloo, F. I., & Varley, J. M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.941 · Cited by 51
Self-citationBirch, J. M., Heighway, J., Teare, M. D., Kelsey, A. M., Hartley, A. L., Tricker, K. J., Crowther, D., Lane, D. P., & Santibanez‐Koref, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.468 · Cited by 49
TP53, hChk2, and the Li-Fraumeni Syndrome
Varley, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:117 · Cited by 43
Self-citationVarley, J. M., McGown, G., Thorncroft, M. R., Cochrane, S. M., Morrison, P., Woll, P. J., Kelsey, A. M., Mitchell, E. L. D., Boyle, J. M., Birch, J. M., et al. (1996) · PubMed · Cited by 40
Self-citationNutting, C. M., Camplejohn, R., Gilchrist, R., Tait, D., Blake, P., Knee, G., Yao, W. Q., Ross, G., Fisher, C., & Eeles, R. A. (2000) · Clinical Oncology · doi:10.1053/clon.2000.9179 · Cited by 39
Germline mutations ofp53 but notp16/CDKN2 orPTEN/MMAC1 tumor suppressor genes predispose to gliomas
Zhou, X., Sanson, M., Hoang‐Xuan, K., Robin, E., Taillandier, L., He, J., Mokhtari, K., Cornu, P., Delattre, J., Thomas, G. D., et al. (1999) · Annals of Neurology · Cited by 26
Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome
Burt, E. C., McGown, G., Thorncroft, M. R., James, L. M., Birch, J. M., & Varley, J. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690313 · Cited by 26
Self-citationAbsence of germline p16 INK4a alterations in p53 wild type Li-Fraumeni syndrome families
Portwine, C., LEES, J., VERSELIS, S., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.8.e13 · Cited by 18
Boyle, J. M., Greaves, M. J., Camplejohn, R. S., Birch, J. M., Roberts, S. A., & Varley, J. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690265 · Cited by 17
Self-citationVarley, J. M., Thorncroft, M. R., McGown, G., Tricker, K. J., Birch, J. M., & Evans, D. G. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(96)00059-3 · Cited by 13
Self-citationOphthalmic genetics: a genealogical guide to sources in England and Wales.
Jay, M. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.946 · Cited by 9
CHEKs and balances: accounting for breast cancer
Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng0502-3 · Cited by 7
Cited by
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
“cgi?id=151623">Li-Fraumeni syndrome who inherit one faulty TP53 allel”
BackgroundHereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Metadata
- Authors
- Varley, J. M.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2003-02-27
- Volume
- 21
- Issue
- 3
- Pages
- 313-320
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2157455826
- Cited by
- 430
- References
- 66
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.